source
- FDA details flexibilities for new cell and gene therapies to leverage past dataThe FDA is further explaining to cell and gene therapy developers the types of prior knowledge companies can leverage for clinical, nonclinical and manufacturing-related work, according to new CBER…Endpoints · 2mo ago↗ source
- Anti-aging biotech NewLimit raises $435M at $3B+ valuationThe Bay Area startup NewLimit has closed one of biotech's largest private financings of 2026 and expects to start human testing next year for its first anti-aging drug candidate. NewLimit said Tues…Endpoints · 2mo ago↗ source
- Eli Lilly issues data sharing ultimatum to 340B hospitalsSelect hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have until Monday to comply, are urging the government to intervene.